Sign in to view content

Benefits and Value of Treatment for Diabetic Macular Edema

Paul Hahn, MD, PhD, FASRS

Video
Published 2022

Related

Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies
David M. Brown, MD
Updates from the Field
2021
Diabetic Retinopathy Lesion Types and Distribution on Ultra-Widefield Imaging and the Risk for Disease Worsening Over Time
Paolo Antonio S. Silva, MD
Annual Meeting Talks
2024
Is It Necessary to Peel Internal Limiting Membrane in Diabetic Vitrectomy
Stanley Chang, MD
Updates from the Field
2022

Category: Diabetic Retinopathy

See more